DANIELLE FORTE: Open Payments
NPI 1780972810 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 67 payments from 16 companies in 2025. Trend: 2023 $2,087 · 2024 $1,220 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $312 |
| Novo Nordisk Inc | 11 | $187 |
| GlaxoSmithKline, LLC. | 7 | $165 |
| Lilly USA, LLC | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Exact Sciences Corporation | 6 | $91 |
| Astellas Pharma US Inc | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| SHIELD THERAPEUTICS INC | 1 | $74 |
| PFIZER INC. | 3 | $55 |
Products named: JARDIANCE, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, Kerendia, The Cologuard Plus Collection Kit, Veozah, ACCRUFER.
Industry payments across TX — which companies pay providers there.
